Concepedia

Anthony Kreamer

AK

5

Publications

284

Citations

5

H-Index

2006

Active since

Affiliations

Merck & Co., Inc., Rahway, NJ, USA (United States)(Current)

Rosetta Stone (United States)

Anthony Kreamer is an author at Merck & Co., Inc., Rahway, NJ, USA (United States) specializing in medicine, cell signaling, and high-throughput screening.

Top concepts

Publications per year

2006–2010

5

Publications

5

Median Absolute Deviation to Improve Hit Selection for Genome-Scale RNAi Screens

Namjin Chung, Xiaohua Douglas Zhang, Anthony Kreamer et al. · SLAS DISCOVERY · 2008 · 193 citations · Full text

Identification of small molecule antagonists of the human mas-related gene-X1 receptor

Priya Kunapuli, Seungtaek Lee, Wei Zheng et al. · Analytical Biochemistry · 2006 · 32 citations

, , +9

Identification of Small-Molecule Modulators of Mouse SVZ Progenitor Cell Proliferation and Differentiation Through High-Throughput Screening

Yaping Liu, Raul Lacson, Jason Cassaday et al. · SLAS DISCOVERY · 2009 · 23 citations · Full text

Multiplexed Assays by High-Content Imaging for Assessment of GPCR Activity

D. A. Ross, S. Lee, Vladimı́r Reiser et al. · SLAS DISCOVERY · 2008 · 22 citations · Full text

A 1,536-Well Ultra-High-Throughput siRNA Screen to Identify Regulators of the Wnt/β-Catenin Pathway

Namjin Chung, Shane Marine, Emily A. Smith et al. · Assay and Drug Development Technologies · 2010 · 14 citations

, , +22

Rows per page

1–5 of 5